NYC urges state to allow affordable drug manufacturing

File Res 0427-2026 ("NYC urges state to allow affordable drug manufacturing") is before Nyc and has not been decided. Latest step (April 16, 2026): Laid Over in Committee.

Nyc file Res 0427-2026, before Nyc. No action in 215 days as of 2026-04-16.

What it does

Non-binding call for action on future legislation This is a resolution—a request to the state legislature to pass separate legislation (S.4786/A.8345A)—and does not itself enact any law or change any rules.

The bigger picture

If enacted downstream, could lower prescription drug costs The underlying bill (S.4786/A.8345A) proposes to authorize in-state drug manufacturing to reduce medication prices, but that outcome depends entirely on whether the state legislature passes it separately.

What to watch

Resolution has no binding force on state officials Even if passed, this resolution does not compel the Assembly or Governor to act on the underlying drug manufacturing bill, and the proposal itself has not yet advanced in state committee.

Read the official record for Res 0427-2026

See everything up for a vote · This week in Nyc · See what we have filed with the clerk